Bejelentkezés Regisztrálj ingyen

Cotinga Pharmaceuticals Rövid % úszó

Mi az Cotinga Pharmaceuticals Rövid % úszó?

A Rövid % úszó az Cotinga Pharmaceuticals, Inc. - 0.00%

Mi a Rövid % úszó meghatározása?



A lebegő rövid százalékos aránya a részvények rövidítése az úszóhoz viszonyítva, százalékban kifejezve.

Short percentage of float, or short interest ratio, is calculated by taking the total amount of shares shorted and dividing it by the total amount of shares available for trade. It is an indirect metric of investor sentiment. When short percentage of float is high, above 40%, it implies company investors hope shares will decline in value. The percentage is used by both fundamental and technical traders to identify trends. The short percentage of float can also be calculated for entire exchanges to determine the sentiment of the market as a whole. If it is high of around five or greater for an exchange, this can be taken as a bearish signal, and vice versa.

Rövid % úszó a Health Care szektor a TSXV-on cégekben a Cotinga Pharmaceuticals -hoz képest

Mit csinál Cotinga Pharmaceuticals?

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

rövid % úszó -hoz hasonló cégek Cotinga Pharmaceuticals